Allogeneic "Zombie Cell" as Off-The-Shelf Vaccine for Postsurgical Cancer Immunotherapy.

MLA

Li, Bo, et al. “Allogeneic ‘Zombie Cell’ as Off-The-Shelf Vaccine for Postsurgical Cancer Immunotherapy.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany), vol. 11, no. 13, Apr. 2024, p. e2307030. EBSCOhost, https://doi.org/10.1002/advs.202307030.

APA

Li, B., Zhang, P., Li, J., Zhou, R., Zhou, M., Liu, C., Liu, X., Chen, L., & Li, L. (2024). Allogeneic “Zombie Cell” as Off-The-Shelf Vaccine for Postsurgical Cancer Immunotherapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 11(13), e2307030. https://doi.org/10.1002/advs.202307030

Chicago

Li, Bo, Ping Zhang, Junlin Li, Rui Zhou, Minglu Zhou, Chendong Liu, Xi Liu, Liqiang Chen, and Lian Li. 2024. “Allogeneic ‘Zombie Cell’ as Off-The-Shelf Vaccine for Postsurgical Cancer Immunotherapy.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11 (13): e2307030. doi:10.1002/advs.202307030.